These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14097629)

  • 1. [ATTEMPTED THERAPY OF SEVERE FORMS OF DIABETES MELLITUS WITH A BIGUANIDE PREPARATION "GLUCOPHAGE" (LA 6023)].
    MICULINIC R; JAKSIC Z; SKRABALO Z
    Lijec Vjesn; 1963 Nov; 85():1279-86. PubMed ID: 14097629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic possibilities in diabetes mellitus with biguanides. Clinical experiences in 122 diabetics with dimethylbiguanide(Glucophage)].
    Berger W; Constam GR; Siegenthaler W
    Schweiz Med Wochenschr; 1966 Oct; 96(40):1335-42. PubMed ID: 5954279
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIENCE WITH THE BIGUANIDE "GLUCOPHAGE"].
    PUCHEGGER R
    Wien Klin Wochenschr; 1964 May; 76():335-7. PubMed ID: 14222131
    [No Abstract]   [Full Text] [Related]  

  • 4. [The importance of lactate acidosis as a side effect of biguanide therapy].
    Förster H
    Fortschr Med; 1976 Dec; 94(35-36):2065-71. PubMed ID: 1010516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1980 Apr; 92(8):266-9. PubMed ID: 6996339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of diabetes mellitus with long-acting biguanides].
    Kliachko VR; Perelygina AA; Mazovetskiĭ AG; Slavina LS
    Probl Endokrinol (Mosk); 1976; 22(3):22-6. PubMed ID: 935083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the action of a biguanide (N,N-dimethylguanylguanidine) on a group of 235 diabetic children].
    LESTRADET H; BESSE J; BILLAUD L
    Presse Med (1893); 1960 Feb; 68():391-3. PubMed ID: 14416046
    [No Abstract]   [Full Text] [Related]  

  • 10. Biguanides. A review of history, pharmacodynamics and therapy.
    Schäfer G
    Diabete Metab; 1983; 9(2):148-63. PubMed ID: 6352352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes treatment with biguanides. Metformin and the biguanide effect].
    Knick B; Knick J
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):739-42. PubMed ID: 6415421
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione].
    Masuda K; Terauchi Y
    Nihon Rinsho; 2010 May; 68(5):969-75. PubMed ID: 20446599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biguanides: reasons for withdrawal of drugs and remaining indications].
    Bolzano K
    Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
    Tatoń J; Kowalik-Borówka E
    Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704
    [No Abstract]   [Full Text] [Related]  

  • 17. New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
    Abbas SY; Basyouni WM; El-Bayouk KAM; Tohamy WM; Aly HF; Arafa A; Soliman MS
    Drug Res (Stuttg); 2017 Oct; 67(10):557-563. PubMed ID: 28651259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of diabetes mellitus with N,N-dimethylguanylguanidine (LA. 6023, glucophage)].
    STERNE J
    Therapie; 1959; 14():625-30. PubMed ID: 13834497
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
    Pilger E; Schmid P; Goebel R
    Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.